Evidence for Linkage Disequilibrium Between FcγRIIIa-V158F and FcγRIIa-H131R Polymorphisms in White Patients, and for an FcγRIIIa-Restricted Influence on the Response to Therapeutic Antibodies

被引：53

作者：

Lejeune, Julien ^{[1
]}

Thibault, Gilles ^{[2
,3
]}

Ternant, David ^{[1
]}

Cartron, Guillaume ^{[4
,5
]}

Watier, Herve ^{[2
]}

Ohresser, Marc ^{[1
]}

机构：

[1] Univ Tours, CNRS, Unite Mixte Rech 6239, Tours, France

[2] Ctr Hosp Reg Univ Tours, Immunol Lab, Tours, France

[3] Univ Auvergne Clermont 1, Clermont Ferrand, France

[4] INSERM, U847, Montpellier, France

[5] Ctr Hosp Univ Lapeyronie, Serv Hematol & Biotherapies, Montpellier, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 33期

关键词：

D O I：

10.1200/JCO.2008.19.4118

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：5489 / 5491

页数：4

共 17 条

[1]

[Anonymous], 1997, REGRESSION MODELS CA

[2]

BIBEAU F, 2008, J CLIN ONCOL S, V26, pS579

[3] A FORTRAN PROGRAM FOR THE CALCULATION AND ANALYSIS OF 2-LOCUS LINKAGE DISEQUILIBRIUM COEFFICIENTS [J].

BLACK, WC ;

KRAFSUR, ES .

THEORETICAL AND APPLIED GENETICS, 1985, 70 (05) :491-496

[4] Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene [J].

Cartron, G ;

Dacheux, L ;

Salles, G ;

Solal-Celigny, P ;

Bardos, P ;

Colombat, P ;

Watier, H .

BLOOD, 2002, 99 (03) :754-758

[5]

Foster CHK, 2002, P AN M AM SOC CLIN, V21, p57a

[6] Single agent rituximab in patients with follicular or mantle cell lymphoma:: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system:: a study of the Swiss Group for Clinical Cancer Research (SAKK) [J].

Ghielmini, A ;

Rufibach, K ;

Salles, G ;

Leoncini-Franscini, L ;

Léger-Falandry, C ;

Cogliatti, S ;

Fey, M ;

Martinelli, G ;

Stahel, R ;

Lohri, A ;

Ketterer, N ;

Wernli, A ;

Cerny, T ;

Schmitz, SFH .

ANNALS OF ONCOLOGY, 2005, 16 (10) :1675-1682

[7]

*INS CORP, 2002, S PLUS 6 US GUID

[8] FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma [J].

Kim, Dong Hwan ;

Du Jung, Hee ;

Kim, Jong Gwang ;

Lee, Je-Jung ;

Yang, Deok-Hwan ;

Park, Yeon Hee ;

Do, Young Rok ;

Shin, Ho Jin ;

Kim, Min Kyoung ;

Hyun, Myung Soo ;

Sohn, Sang Kyun .

BLOOD, 2006, 108 (08) :2720-2725

[9] Variant genotypes of the low-affinity Fcγ receptors in two control populations and a review of low-affinity Fcγ receptor polymorphisms in control and disease populations [J].

Lehrnbecher, T ;

Foster, CB ;

Zhu, SX ;

Leitman, SF ;

Goldin, LR ;

Huppi, K ;

Chanock, SJ .

BLOOD, 1999, 94 (12) :4220-4232

[10] Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer [J].

Musolino, Antonino ;

Naldi, Nadia ;

Bortesi, Beatrice ;

Pezzuolo, Debora ;

Capelletti, Marzia ;

Missale, Gabriele ;

Laccabue, Diletta ;

Zerbini, Alessandro ;

Camisa, Roberta ;

Bisagni, Giancarlo ;

Neri, Tauro Maria ;

Ardizzoni, Andrea .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) :1789-1796

← 1 2 →